Strategic partnerships

We will promote a holistic approach which is based on multidisciplinarity and collaboration with strategic national and international partners in the private, public and voluntary sectors.

Long-term partners and funding bodies include the Chief Scientist Office and the National Institute for Health Research, and industry leaders such as EDF Energy, Doble, ScottishPower and Pfizer.

We also work collaboratively as a partner in five SFC-funded Innovation Centres, including the Construction Scotland Innovation Centre, the DataLab, the Oil and Gas Innovation Centre (OGIC), CENSIS (The Centre for Sensors and Imaging Systems) and the Digital Health Institute, launched to stimulate university-industry innovation.

As well as collaborating with partners in Scotland, we work with international health organisations to raise awareness of and tackle global health challenges such as viral hepatitis and healthcare associated infections.

R&D Collaboration

GCU’s research expertise in high voltage condition monitoring has had international impact. Using its high voltage labs, GCU researchers work with companies including Doble Engineering, EDF Energy, Scottish Power, Wuhan Electrical Power Company and Drax to improve the asset management of high voltage equipment such as cables, motors and generators, to reduce maintenance and repair costs by millions of pounds and ensure reliable power generation and distribution.

Working closely with GCU on a number of research and development projects in recent years, Doble brought new investment to Scotland’s engineering sector through the launch of the Doble Innovation Centre for On-Line Systems at GCU in 2013. Developments to date include the PDS100 partial discharge surveyor, which is successfully used in many power industry sites worldwide. Further developments in integrated condition monitoring tools will help the electric supply industry around the world as it moves towards on-line monitoring systems and predictive maintenance services.

Scottish research pooling

GCU is a member of a number of research collaborations with other higher education institutions, designed to build dynamic collaborations between research departments to provide Scotland’s universities with a competitive advantage.

These Scottish Research Pooling collaborations include:

The Scottish Informatics and Computer Science Alliance (SICSA) is a collaboration of Scottish Universities whose goal is to develop and extend Scotland’s position as a world leader in Informatics and Computer Science research and education.

The Scottish Research Partnership in Engineering (SRPE) comprises collaboration between three regional research partnerships based around institutions in Edinburgh, Glasgow, Aberdeen and Dundee. Pan-Scottish research themes include: civil engineering, technologies for high value manufacturing, engineering at the life sciences interface, communications, and energy.

The Scottish Institute for Policing Research is a strategic collaboration between 12 of Scotland's universities and the Police Service of Scotland, offering a range of opportunities for conducting relevant, applicable research to help the police meet the challenges of the 21st century and for achieving international excellence for policing research in Scotland.

The Scottish Centre for Crime and Justice Research is a collaboration of several Scottish universities aiming to contribute to the development of policy, practice and public debate about crime and justice.

World Hepatitis Summit

The World Hepatitis Summit (September 2015) was a joint World Health Organization (WHO) and World Hepatitis Alliance (WHA) event hosted by the Scottish Government and supported by GCU and Health Protection Scotland.

It brought together policy makers, patients, civil society, physicians and representatives from each of the World Hepatitis Alliance’s 200 patient group member organisations.

This three-day meeting was the world’s first response to last year’s World Health Assembly Resolution calling for concerted action to reverse the ever-rising death toll from viral hepatitis. Viral hepatitis now kills more people than HIV/AIDS, TB and malaria and has become the 7th biggest annual killer globally.

Hosted by the Scottish Government - widely recognised as having a world-leading approach towards the testing and treatment of hepatitis C – the three-day Summit launched the draft World Health Organization (WHO) Global Health Sector Strategy with its targets for 2030 that pave the way for the elimination of viral hepatitis and on the national action required to reach those targets.

Scottish Healthcare Associated Infection Prevention Institute

GCU is a partner in a £4.2m virtual research network with a programme of work streams aimed at tackling healthcare associated infections.

The five-year Scottish Healthcare Associated Infection Prevention Institute (SHAIPI) is a consortium of universities and NHS partners, funded by the Scottish Government.

GCU researchers are working with the University of Glasgow, the NHS, the University of Strathclyde, University of Edinburgh, University of Dundee and University of St Andrews to develop an internationally recognised institute for excellence in healthcare associated infections research.

This work will span molecular epidemiology, informatics and applied infection prevention and control, the latter being led by a GCU team including Professor Jacqui Reilly, Dr Kay Currie, Dr Christina Knussen, Dr Sue Lang and Dr Lesley Price. A PhD studentship will also be supported by GCU.

GCU is leading the work stream on applied infection prevention and control. Researchers will aim to provide new policy and practice impact in NHS Scotland and internationally by providing evidence for standard and transmission based infection control precautions such as hand hygiene and glove use, and providing evidence of the patient experience and acceptability of infection prevention and control related interventions.

This new research builds on previous GCU-led research which has contributed to infection prevention in healthcare in the UK and Europe by stimulating policy debate and investment in new healthcare practice and influencing policy decisions, evidence guidelines, and educational practices.